Leukemia D007938

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Leukemia

Description

A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)   MeSH

Subtype Terms (9)

Leukemia, Hairy Cell
88 drugs (61 approved, 27 experimental)

Leukemia, Lymphoid
134 drugs (80 approved, 54 experimental)

Leukemia, Mast-Cell
23 drugs (16 approved, 7 experimental)

Leukemia, Myeloid
76 drugs (46 approved, 30 experimental)

Leukemia, Plasma Cell
44 drugs (34 approved, 10 experimental)

Leukemia, Radiation-Induced
 


Phase 3 Indicated Drugs (111)

Phase 2 Indicated Drugs (188)

Phase 1 Indicated Drugs (149)


Organization Involved with Phase 4 Indications (108)

Organization Involved with Phase 3 Indications (367)

Aamu Pediatric Cancer Foundation

AbbVie

Accutest Research Laboratories (I) Pvt. Ltd.

Acerta Pharma

Acreditar - Associação de Pais e Amigos das Crianças com Cancro

Actinium Pharmaceuticals

Agios Pharmaceuticals, Inc.

Akdeniz University

Albert Einstein Israelite Hospital

All India Institute of Medical Sciences

ALL SCTped Forum

Amneal Pharmaceuticals

Ampang Hospital, Malaysia

Anhui Medical University

Antisoma Research

Aqualis

Arbeitsgemeinschaft medikamentoese Tumortherapie

Ariad Pharmaceuticals

Arog Pharmaceuticals, Inc.

Assistance Publique - Hôpitaux de Paris

AstraZeneca

Avillion

Azienda Ospedaliera San Gerardo di Monza

AZ Sint-Jan

Bangabandhu Sheikh Mujib Medical University

Barts & The London NHS Trust

Basilea Pharmaceutica

Baxalta

Bayer

BeiGene

Beijing InnoCare Pharma Tech Co., Ltd.

Belgian Hematological Society

Binzhou Medical University

Biogen

Blood and Marrow Transplant Clinical Trials Network

Boehringer Ingelheim

Cairo University

Canadian Cancer Trials Group

Cancer and Leukemia Group B (CALGB)

Cancer Research UK

Cancer Trials Ireland

Cardiff University

Case Western Reserve University

Catholic University of Korea

Celator Pharmaceuticals

Celgene

Center for International Blood and Marrow Transplant Research

Centocor

Central European Leukemia Study Group

Central Hospital, Zibo

Central South University

Centre Henri Becquerel

Cephalon

Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.

Changzhou No.2 People's Hospital

Charles University

Children Oncology Group, USA

Children's Cancer and Leukaemia Group

Children's National Medical Center

Chimeric Therapies

Chimerix

Chiron

Christian Medical College, Vellore, India

Chugai

CHU Haut-Leveque Pessac 33604 France

CHU Henri Mondor

City University of Hong Kong

Clinipace LTD

Cohen Children's Medical Center of New York

Columbia University

Cook Children's Medical Center

Copernicus Memorial Hospital

Cristália Produtos Químicos Farmacêuticos Ltda.

CTC Bio, Inc.

CTI BioPharma

Cyclacel Pharmaceuticals, Inc.

Daiichi Sankyo

Dartmouth University

Delta-Fly Pharma, Inc.

Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)

Dongguan Kanghua Hospital

Duke University

Dutch Childhood Oncology Group

Dynamic Science S.L.

Dynamic Solutions

Eastern Cooperative Oncology Group

ECOG-ACRIN Cancer Research Group

Eisai

Eli Lilly

Enzon

Erasmus University Rotterdam

ERYtech Pharma

European Union

European Working Group of MDS in Childhood

Ev. Krankenhaus Essen-Werden

Facet Biotech

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

First People's Hospital of Chenzhou

François Rabelais University

Free University of Amsterdam

Free University of Brussels

French Innovative Leukemia Organisation

Friedrich Schiller University

Fundação Rui Osório de Castro

Gaia AG

Gamida Cell

Genentech

Genta

German CLL Study Group

German CML Study Group

German Research Foundation

Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany

Ghent University

GlycoMimetics, Inc.

Gottfried Wilhelm Leibniz Universität Hannover

Government of Canada

Government of China

Government of France

Government of India

Government of Japan

Government of Malaysia

Government of Russia

Groupe d'etude et de travail sur les leucemies aigues promyelocytaires

Groupe Francophone des Myelodysplasies

Grupo Español de Leucemia Linfocítica Crónica (GELLC)

Grupo Português De Leucemias Pediátricas

Gruppo Italiano Trapianto di Midollo Osseo

Guangxi Medical University

Hacettepe University

Haemato Oncology Foundation for Adults in the Netherlands

HagaZiekenhuis

Hamad Medical Corporation

Harbin Medical University

Harvard University

Hebei University

Hebrew University

Helsinn

Henan Medical University

Herbert Irving Comprehensive Cancer Center

Heze Municipal Hospital

Hikma

Hoosier Cancer Research Network

Hopital Americain

Hospital Civil Juan I. Menchaca

Hospital de Pediatria Garrahan

Huai'an Second People's Hospital

Icahn School of Medicine at Mount Sinai

Il-Yang Pharm. Co., Ltd.

Imperial College London

Incyte

Indiana University

Institut Gustave Roussy

Instituto de Investigacion de Cancer de la Infancia y la Adolescencia

Instituto de Investigacion en Cancer de la Infancia y la Adolescencia

Instituto de Medicina Integral Professor Fernando Figueira

IRCCS Ospedale, Rome, Italy

Isfahan University

Istanbul University

Janssen Pharmaceutica NV

Japan Adult Leukemia Study Group

Japan Clinical Oncology Group

Jazz Pharmaceuticals

Jingjiang People's Hospital

Jinlin University

Johns Hopkins University

Justus Liebig University Giessen

Kaiser Permanente

Kanisa Pharmaceuticals

Karolinska Institute

Katholieke Universiteit Leuven

Katmai Oncology Group

Kiadis Pharma

King Faisal Specialist Hospital

King Faisal University

Klinikum Leverkusen gGmbH

Kunming Medical University

Laval University

Leiden University

Leukemia Research Fund

Linyi People's Hospital

Loxo Oncology

Loyola University

Ludwig Maximilians University

Lundbeck

Lund University

Luye Pharma

Maine Children's Cancer Program

Masaryk University

Maxim Pharmaceuticals

Mayo Clinic

McMaster University

Medical University Innsbruck

Medical University of Vienna

MedImmune

Med. Klinik III, Klinikum Leverkusen gGmbH, Germany

Mesoblast, Inc.

Millennium Pharmaceuticals

MolMed S.p.A.

Morristown Memorial Hospital

Mundipharma

Nagoya University

Nanchang University

Nanjing University

Napo Pharmaceuticals

National Cancer Institute, France

National Cancer Institute (NCI)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute of General Medical Sciences (NIGMS)

National Institute of Nursing Research (NINR)

National Institutes of Health (NIH)

National Marrow Donor Program

National University of Malaysia

Neovii Biotech

Newcastle University

New York Blood Center

New York University

NordForsk

Nordic CLL Study Group (NCLLSG)

Northern Italy Leukemia Group

Northwell Health

Northwestern University

Novo Nordisk

Ochsner Health System

Octapharma

Ohio State University

OncoImmune, Inc.

Oregon Health and Science University

Parexel

People's Hospital of Rizhao

Pharmacyclics

Physicians, Innovations, Science for Children Fund

Polish Adult Leukemia Group

Poznan University

Procter and Gamble

Radboud University

Rafael Pharmaceuticals Inc.

Riverside Haematology Group

Royal Infirmary - Castle

Royal Liverpool & Broadgreen University Hospitals NHS Truts

Royal Marsden Hospital NHS Trust

Rutgers University

San Jorge Children's Hospital, Puerto Rico

Schering AG

Seattle Genetics

Sellas Life Sciences Group

Servier

Shandong Lanjin Pharmaceuticals Co.,Ltd

Shanghai Ruijin Hospital North

Shengli Oilfield Central Hospital

Shijiazhuang Pharma Group (CSPC)

Shire

Sichuan University

Societe Francaise Oncologie Pediatrique

Southwest Oncology Group

Spectrum Pharmaceuticals

Stanford University

St. Anna Kinderkrebsforschung

State University of New York, Buffalo

St. Jude Children's Hospital

Sunesis Pharmaceuticals

Swiss Group for Clinical Cancer Research

Tai'an Central Hospital

Taishan Medical University

Technion University

Temple University

Teva

Texas Transplant Institute

TG Therapeutics, Inc.

The Canadian Blood and Marrow Transplant Group

The Christie NHS Foundation Trust

The First People's Hospital of Lianyungang

The Israeli CLL Study Group (ICLLSG)

The Leukemia and Lymphoma Society

The Second People's Hospital of Huai'an

The Swedish Childhood Cancer Foundation

The Swedish Research Council

The University of Hong Kong

The University of Texas, Dallas

The Vaccine Company

Tianjin Medical University

Tufts University

Tulane University

Universidad Carlos III Madrid

Universitaetsklinikum Schleswig-Holstein

University Hospital Freiburg

University of Adelaide

University of Bern

University of Birmingham

University of Bologna

University of Bordeaux

University of Bratislava

University of Brescia

University of California, Irvine

University of California, Los Angeles

University of Chicago

University of Cologne

University of Colorado

University of Edinburgh

University of Florence

University of Florida

University of Freiburg

University of Genoa

University of Glasgow

University of Guadalajara

University of Hamburg

University of Heidelberg

University of Helsinki

University of Jena

University of Kansas

University of Kiel

University of Lausanne

University of Liege

University of Lille

University of Liverpool

University of Lorraine

University of Lyon

University of Mannheim

University of Medicine and Dentistry of New Jersey

University of Michigan

University of Milan

University of Minnesota

University of Montreal

University of Munster

University of Nagasaki

University of Nantes

University of New South Wales

University of Nottingham

University of Oslo

University of Paris

University of Pennsylvania

University of Perugia

University of Pittsburgh

University of Rochester

University of Roma La Sapienza

University of Rome Tor Vergata

University of Tartu

University of Texas, San Antonio

University of Toronto

University of Toulouse

University of Udine

University of Ulm

University of Versailles

University of Virginia

University of Washington

University of Western Australia

University of Wisconsin

University of Witten/Herdecke

University of Zagreb

US Oncology

Utrecht University

Vall d'Hebron Institute of Research, Galatea Clinic

Vanderbilt University

Vastra Gotaland Region

Verastem, Inc.

Vion Pharmaceuticals

Virginia Commonwealth University

Vita-Salute University of Milano. Italy

Wake Forest University

Wayne State University

Weifang Medical University

Weihai Municipal Hospital

Willamette Valley Cancer Institute

WiSP GmbH

Xuzhou Medical University

Zhangjiagang First People's Hospital

Zhejiang University

Zibo City First Hospital

Organization Involved with Phase 2 Indications (510)

AAIPharma

Aalborg University

Abbott

Abiogen Pharma

Academic and Community Cancer Research United

Acibadem University

Acrotech Biopharma LLC

ADC Therapeutics SARL

Advancell - Advanced In Vitro Cell Technologies, S.A.

Aegera Therapeutics

AEterna Zentaris

Agenus Inc.

Ain Shams University

Akinion Pharmaceuticals AB

Alexion

ALFA cooperative Group

Ambit Biosciences

American Cancer Society, Inc.

Ångstrom Pharmaceuticals

AnorMED

AO GENERIUM

AOP Orphan Pharmaceuticals AG

Aprea Therapeutics AB

Aptevo Therapeutics

Aptose Biosciences Inc.

argenx

Array BioPharma

Asana BioSciences

Ascentage Pharma Group Inc.

Ascenta Therapeutics

Aslan Pharmaceuticals

ASL della provincia

Assisi Foundation

Associazione Italiana per la Ricerca sul Cancro

Asterias Biotherapeutics

Australasian Leukaemia and Lymphoma Group

Autolus Limited

AVEO Pharmaceuticals

Azienda Ospedaliera Antonio Cardarelli

Azienda Ospedaliera Ospedale Civile di Legnano

Azienda Ospedaliera Universitaria Senese

Azienda Osperdaliera Vincenzo Cervello Divisione

Azienda ULSS 12 Veneziana

Bambino Gesù Hospital and Research Institute

Baptist Health

Baylor University

Beat AML

Beijing Boren Hospital

Bellicum Pharmaceuticals

Ben Gurion University

BerGenBio ASA

Betta Pharmaceuticals Co.,Ltd.

Bio-Cancer Treatment International Limited

BioCryst

Biodesix Inc.

Bioenvision

BioLineRx, Ltd.

Biologics, Inc.

BioMAS Ltd

BioMed Valley Discoveries, Inc

Bioniz Therapeutics

Bio-Path Holdings, Inc.

BioSight Ltd.

Biosuccess Biotech Co., Ltd.

Bocage University

Boston University

BreakThrough Therapeutics

Brown University

CABYC

Calithera Biosciences

Callisto Pharmaceuticals

Cancer Biotherapy Research Group

CancerCare Manitoba

Cancer Treatment Centers of America

Cantex Pharmaceuticals

Capital Medical University

Cardiff Oncology

Celerion

Celldex Therapeutics

Cellerant Therapeutics

Cell Genesys

Cellgenix

Cell Therapy Catapult

Centaurus Biopharma Co., Ltd.

Central Maryland Oncology Center

Centre Leon Berard

Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Centro Goiano de Oncologia

Chao Family Comprehensive Cancer Center

ChemGenex Pharmaceuticals

Children's Hospital Los Angeles

Chinese University of Hong Kong

Chonbuk National University

Chongqing Medical University

Chongqing Precision Biotech Co., Ltd

Chonnam National University

Chroma Therapeutics

Chronic Lymphocytic Leukemia Research Consortium

Chu De Liège

CHU Hart Leveque

CHU Mont-Godinne

Chung-Ang University

City of Hope National Medical Center

Clear Creek Bio, Inc.

Clinical Service, China

Clinica Universidad de Navarra

Clinique Charcot

CLL Topics

Colorado Blood Cancer Institute

Complessa di Ematologia and Dir Departmento

Cookies for Kids' Cancer

Cure CML Consortium

Curie Institute

Cylene Pharmaceuticals

CytRx

CZECRIN - Czech Clinical Research Infrastructure Network

Daegu Catholic University

Data Matrix, LTD

DCPrime BV

Department of Health and Human Services

Department of Health, United Kingdom

Department of Veteran Affairs

DKMS Stiftung Leben Spenden

Doris Duke Charitable Foundation

Drexel University

Dutch Cancer Society

East Carolina University

Eleos, Inc.

Ellipses Pharma

Emergent BioSolutions

Emory University

Epidemiological and Clinical Research Information Network

European Commission

European Group for Blood and Marrow Transplantation

European Intergroup Study on Post Induction Treatment of Philadelphia Positive Acute Lymphoblastic Leukaemia with Imatinib

European LeukemiaNet

Ewha Womans University

Exelixis

F2G Ltd.

Faculdade de Medicina do ABC

Fate Therapeutics

Federal University of Health Science of Porto Alegre

Federal University of Rio de Janeiro

Federal University of Rio Grande do Sul

First People's Hospital of Foshan

Fondation ARC

Fondazione Giovanni Pascale

Fondazione Italiana Diabete Onlus

Fondazione Matilde Tettamanti Menotti De Marchi Onlus

Food and Drug Administration

Forma Therapeutics, Inc.

Fortress Biotech

Free State University

Fresenius

Froedtert Memorial Lutheran Hospital

Fujifilm

Fundacao Hospital Amaral Carvalho

Fundación Teófilo Hernando, Spain

Fundació Sant Joan de Déu

Fusion Pharma LLC

Garden State Cancer Center

Gateway for Cancer Research

Genitope Corporation

Georgetown University

George Washington University

German Cancer Research Center

Glycostem Therapeutics BV

GMP BIO Co., LTD.

GOELAMS Cooperative Group

Golden Biotechnology Corp.

Government of Brazil

Government of Italy

Government of Korea

Government of Mexico

Government of Singapore

Government of Spain

Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias

Grupo Cooperativo de Hemopatías Malignas

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Grupo Espanol de trasplantes hematopoyeticos y terapia celular

Guangdong Pharmaceutical University

GWT-TUD GmbH

Hackensack University Medical Center

Hanmi Pharmaceutical

Hannover Clinical Trial Center GmbH

Hannover Medical School

Hanyang University

Hefei University

Hematologics, Inc

Henan University of Traditional Chinese Medicine

Hengrui Therapeutics, Inc.

Hoag Memorial Hospital Presbyterian

HOANNJ-Carol G. Simon Cancer Center

Hôpital Mignot, Versailles Paris

Hopital Rene Huguenin_Intitut Curie_Paris

Hospital Auxilio Mutuo

Hospital Avicenne

Hospital Brigadeiro

Hospital de Clinicias da UICAMP

Hospital Erasto Gaertner

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Hospital La Paz

Hospital Nossa Senhora da Conceicao

Hospital San Pedro de Alcantara

Hospital Santa Marcelina, Sao Paulo, Brasil

Hospital Universitario Ramon y Cajal

Humboldt University

Hybrigenics

ICON

I-Mab Biopharma

Imamura Bun-in Hospital

Immune System Key Ltd

Immunex

ImmunogenX

Immunomedics

Immunovative Therapies

INC Research

Infinity Pharmaceuticals, Inc.

Inha University

Innate Pharma

Innovative Therapies For Children with Cancer Consortium

Innovent Biologics (Suzhou) Co. Ltd.

Inovio Pharmaceuticals

Institut Bergonié

Institut de Cancérologie de la Loire (ICLN)

Institut de Cancerologie de l'Ouest Paul Papin

Institute of Hematology and Blood Transfusion, Czech Republic

Instituto de Oncologia Pediatrica - GRAACC Grupo de Apoio as Adolescente e a Crianca com Cancer - UNIFESP

Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti

Instituto Mexicano del Seguro Social

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Institut Paoli-Calmettes

Invectys

inVentiv

IO Biotech

Iovance

IQVIA

IRCCS Centro di Riferimento Oncologico della Basilicata

Istituti Ospitalieri di Cremona

Istituto Nazionale per lo Studio e la Cura dei Tumori

Istitutp di Ematologia ed Oncologia Medica

Italfarmaco

James Graham Brown Cancer Center

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Jin Yang Pharmaceutical

Johann Wolfgang Goethe University Hospital

JP Moulton Charitable Foundation

Julius-Maximilians University

Juno Therapeutics, Inc.

Juventas Therapeutics, Inc.

Kansas Bioscience Authority

Kanto CML Study Group

Kartos Therapeutics, Inc.

Karyopharm Therapeutics Inc

Keimyung University

Keio University

Keryx

Kite Pharma, Inc.

Klinika Okulistyki

Klinik Hirslanden, Zurich

Klinikum Wels-Grieskirchen

Konkuk University

Korea Research Institute of Bioscience and Biotechnology

Korea Research Institute of Bioscience & Biotechnology

Kumamoto University

Kura Oncology, Inc.

Kyowa Hakko Kirin

La Jolla Pharmaceutical Company

Leadiant Biosciences, Inc.

Leo W. Jenkins Cancer Center

Liberty Hematology and Oncology

Ligand Pharmaceuticals

Louisiana State University

Luoyang Central Hospital

Lymphoma Research Foundation

MaaT Pharma

Mario Negri Institute

Marker Therapeutics

Matinas Biopharma, Inc

McGill University

Medical University of South Carolina

MediGene

Memgen, LLC

Memorial Sloan-Kettering Cancer Center

Merck KGaA

Merck Serono

Methodist Cancer Center, Houston, Texas

MethylGene Inc.

Miltenyi Biotec, Inc.

Mirati Therapeutics Inc.

Moleculin, LLC

Monash University

Monter Cancer Center

Moorgreen Hospital, Southampton

MorphoSys

MultiPharma

National Cancer Center, Japan

National Center for Research Resources (NCRR)

National Comprehensive Cancer Network

National Hospital Organisation Nagoya Medical Centre

National Hospital Organization, Mito Medical Center

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute on Aging (NIA)

Nerviano Medical Sciences

Nevada Cancer Institute

NewLink Genetics Inc

New Mexico Cancer Care Alliance

New York Medical College

New York Presbyterian Hospital

Nexus Oncology Ltd

Nippon Medical School

Nohla Therapeutics, Inc.

Nordic CLL Study Group

Nordic MDS Group

North Central Cancer Treatment Group

North Shore Hospital, New Zealand

Northside Hospital, Inc.

Norwegian University of Science and Technology

Novacea

Noxxon AG

NuRx Pharmaceuticals, Inc.

OBiS, Inc

OCT Clinical Trials

OHSU Knight Cancer Institute

Okayama University

Oncoceutics, Inc.

OncoEthix

Onconova Therapeutics, Inc.

OncoTherapy Science, Inc.

OncoVista, Inc.

Onxeo

Onyx

Oshadi Drug Administration

OSI Pharmaceuticals

Ospedale di Bergamo

Ospedale Sant' Eugenio

Ospedale S. Giovanni Bellinzona

Ospedale Valduce, Como

Otsuka

Our Lady of Mercy Medical Center

Pavlov First Saint Petersburg State Medical University

Pennsylvania State University

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Peter MacCallum Cancer Centre

PharmaMar

Philipps University of Marburg

Pierre Fabre

Plexxikon

Point Therapeutics

Polaris Group

Polyphor Ltd.

Portola Pharmaceuticals

PPD

Precision BioSciences, Inc.

PrECOG, LLC.

Prescient Therapeutics, Ltd.

Presidio Ospedaliero Spedali Civili di Brescia

Prism Research

Proacta, Incorporated

Q2 solutions

Race Oncology Ltd

Regione Lombardia

Renato Melaragno

Rhizen Pharmaceuticals SA

Rhode Island Hospital

Rio de Janeiro Federal University

Rocky Mountain Cancer Centers - Denver Midtown

Rush University

Santaris Pharma A/S

Santobono - Pausilipon Hospital

S*BIO

SCRI Development Innovations

Scripps

Second Military Medical University

Selvita S.A.

Sensei Pharmaceuticals, Inc.

Service Clinique des Maladies du Sang

service Hématologie Séniors Hôpital Saint Louis

Sevion Therapeutics

SGX Pharmaceuticals

Shanghai Children Medicine Center

Shanghai GeneChem Co., Ltd.

Shanghai institute of Hematology

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Shanghai Zhangjiang Biotechnology Limited Company

Sheba Medical Center

Shenzhen BinDeBio Ltd.

Shenzhen Geno-Immune Medical Institute

Shenzhen Institute for Innovation and Translational Medicine

Shimousa Hematology Study Group

Simcere Pharmaceutical Co., Ltd

Singapore General Hospital

SmithKline Beecham

SPARC

Spedali Civili di Brescia

Spirogen

Sponsor GmbH

State of Texas

St. Baldrick's Foundation

Stemline Therapeutics, Inc.

Sumitomo

SymBio Pharmaceuticals

Symphony Capital

Syndax Pharmaceuticals

Synimmune GmbH

Syntax for Science

Syros Pharmaceuticals

Takara Bio Inc.

Takeda

TCR2 Therapeutics

Teaching Hospital Královské Vinohrady (FNKV)

Technical University of Denmark

Technical University of Munich

Telios Pharma, Inc.

TetraLogic Pharmaceuticals

Texas Oncology Cancer Center

The Beijing Pregene Science and Technology Company, Ltd.

The Cleveland Clinic

The EMMES Corporation

The First People's Hospital of Yunan Province

The Foundation Institute San Raffaele G. Giglio of Cefalù

The Korean Society of Blood and Marrow Transplantation

The Korean Society of Hematology

The Korean Society of Pediatric Hematology Oncology

The Lymphoma Academic Research Organisation

Theradex

The Royal Bournemouth Hospital

The Scientific and Technological Research Council of Turkey

The Wayne D. Kuni and Joan E. Kuni Foundation

Thomas Jefferson University

Titan Pharmaceuticals

Tokyo Metropolitan Komagome Hospital

Tolero Pharmaceuticals

Trinity College Dublin

Universidad Autonoma de Madrid

Universidade Federal do Parana

Universita' Cattolica del Sacro Cuore

Universita Degli Studi La Sapeinza

Universitair Ziekenhuis Gent

Université catholique de Louvain

University Clermont Auvergne

University Hospital Brno

University Hospital Hradec Kralove

University Hospital of Mont-Godinne

University Hospital of North Norway

University of Alabama, Birmingham

University of Amsterdam

University of Antwerp

University of Bergen

University of Bonn

University of Bristol

University of British Columbia

University of California, Davis

University of California, San Diego

University of California, San Francisco

University of Campinas

University of Cincinnati

University of Colorado, Denver

University of Duesseldorf

University of Duisburg-Essen

University of Erlangen-Nuremberg

University of Exeter

University of Geneva

University of Groningen

University of Illinois at Chicago

University of Iowa

University of Kentucky

University of Leeds

University of Louisville

University of Malaga

University of Manitoba

University of Melbourne

University of Miami

University of Miyazaki

University of Nebraska

University of New Mexico

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Ottawa

University of Oulu

University of Palermo

University of Picardie Jules Verne

University of Regensburg

University of Rennes

University of Rostock

University of Salamanca

University of Salzburg

University of Sao Paulo

University of Seville

University of South Carolina

University of Southern California

University of Southern Denmark

University of Stavanger

University of Sussex

University of Tokyo

University of Tuebingen

University of Utah

University of Vermont

U.O. di Ematologia- Ospedale dell'Angelo - Mestre

Uppsala University

Van Andel Research Institute

Vical

Vilnius University

Washington University in St. Louis

Xanthus Pharmaceuticals, Inc.

Yale University

Yeshiva University

Yonsei University

Zhejiang DTRM Biopharma

ZNA Antwerpen

Organization Involved with Phase 1 Indications (204)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.